The Animal Economics logo
The Animal Economics logo
The Animal Economics amblem

Your Premier Source for AI-Powered Animal Health Business Insights

SOCIAL MEDIA LINKS

LinkedIn page
X account
Instagram profile
Facebook
YouTube channel

Broiler study puts feed conversion at the heart of coccidiosis strategy

20/11/2026

A reported 0.14-point improvement in feed conversion ratio has put a hard production number behind a combined coccidiosis-vaccination strategy. In a Huvepharma study of 110 male Ross broilers, birds vaccinated with HuveGuard MMAT and given the B-Act probiotic feed additive outperformed birds receiving the vaccine alone on that measure. In a business where feed is a defining cost, the result deserves attention even before it is extrapolated beyond the study.

Coccidiosis remains one of poultry production's most persistent economic diseases. The Eimeria parasites behind it can also create the conditions for broader intestinal problems, including necrotic enteritis and dysbacteriosis. HuveGuard MMAT contains attenuated strains of E. maxima, E. mitis, E. acervulina and E. tenella, while B-Act contains Bacillus licheniformis spores intended to support gut function during the vaccination period.

The study used eye-drop vaccination and included B-Act in feed at 0.5 kg per tonne. Alongside the feed-conversion result, the combined programme produced lower Eimeria-lesion scores on days 22 and 29, lower dysbiosis scores and fewer plantar lesions. Huvepharma also reported comparable field observations during summer vaccination programmes in Spain, across three vaccines registered in the EU.

Those are company-reported data, not a promise of a universal farm result. Housing, nutrition, disease pressure, vaccine delivery and flock management will all affect the outcome. Still, the direction is commercially relevant. A health programme that protects feed conversion while controlling a costly intestinal challenge can influence the cost of producing each kilogram of chicken, not simply the clinical condition of the flock.

That is where the study has its value. It frames coccidiosis control as a performance decision with health benefits, rather than treating it as a stand-alone veterinary expense. Integrators now have a concrete result to test against their own production systems.

For further info > Huvepharma

LinkedIn page
X account
Instagram profile
Facebook link
YouTube channel

All rights reserved to The Animal Economics © Copyright 2026 | Web design & implementation: PAQ Consultancy 

This website uses cookies. For details, please see our privacy policy. By clicking on the relevant button or any other element of the page, you consent to the use of cookies.

Reject
OK